# Electronic and magnetic structure of infinite-layer NdNiO2: trace of antiferromagnetic metal

Article · Zhao Liu, Zhi Ren, Wei Zhu, Zhengfei Wang, Jinlong Yang

- Archive id: arxiv:1912.01332
- Published: 2020-05-15
- Venue: npj Quantum Materials
- DOI: https://doi.org/10.1038/s41535-020-0229-1
- arXiv: https://arxiv.org/abs/1912.01332
- Citations: 92
- Source URL: https://doi.org/10.1038/s41535-020-0229-1
- PDF: https://www.nature.com/articles/s41535-020-0229-1.pdf
- Provenance: openalex+arxiv

## Abstract

The recent discovery of Sr-doped infinite-layer nickelate $\\textrm{NdNiO}\_2$ \[D. Li et al. Nature 572, 624 (2019)\] offers an exciting platform for investigating unconventional superconductivity in nickelatebased compounds. In this work, we present a first-principles calculations for the electronic and magnetic properties of undoped parent $\\textrm{NdNiO}\_2$. Intriguingly, we found that: 1) the paramagnetic phase has complex Fermi pockets with 3D characters near the Fermi level; 2) by including electronelectron interactions, 3d-electrons of Ni tend to form $(π, π, π)$ antiferromagnetic ordering at low temperatures; 3) with moderate interaction strength, 5d-electrons of Nd contribute small Fermi pockets that could weaken the magnetic order akin to the self-doping effect. Our results provide a plausible interpretation for the experimentally observed resistivity minimum and Hall coefficient drop. Moreover, we elucidate that antiferromagnetic ordering in $\\textrm{NdNiO}\_2$ is relatively weak, arising from the small exchange coupling between 3d-electrons of Niand also hybridization with 5d-electrons of Nd.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Nickelate & Iron-Based Superconductors](https://space-kitty.com/topics/nickelates-iron-based)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.